FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Rules Needed on Complete Response Letter Transparency: Researchers

Researchers say clear rules are needed for when FDA decides to publicly release complete response letters.

latest-news-card-1
Medical Devices

Alert on Boston Scientifics Angiographic Catheters

FDA issues an Early Alert after becoming aware that Boston Scientific sent a letter to customers recommending all Imager II Angiographic Catheters be ...

latest-news-card-1
Human Drugs

FDA OKs Lilly's Mounjaro to Reduce CV Risk in Adults with Diabetes

FDA approves Eli Lillys Mounjaro (tirzepatide) for lowering the risk of major adverse cardiovascular events.

Biologics

FDA Approves Updated Covid-19 Vaccines for Upcoming Season

FDA approves updated Covid-19 vaccines from Moderna, Pfizer-BioNTech and Novavax/Sanofi for the upcoming vaccination season.

latest-news-card-1
Marketing

FDA Hits Alar Pharmaceuticals Experimental Ketamine Promotion

FDA issues Alar Pharmaceuticals an untitled letter over promotional materials for its investigational ketamine drug, ALA-3000, because they improperly...

latest-news-card-1
Human Drugs

Study Finds Drug Approvals Increasingly Rely on Fewer Trials

FDAs approval of new drugs is increasingly being supported by fewer clinical studies.

latest-news-card-1
Human Drugs

First Oral Drug Indicated to Treat Dermatomyositis Approved

The agency approves Priovant Therapeutics Lisraya (brepocitinib) tablets for treating dermatomyositis in adults.

latest-news-card-1
Human Drugs

Boebert Bill to Ease Botanical Drug Development

Rep. Lauren Boebert introduces legislation to remove some barriers to the development of botanical drugs.

latest-news-card-1
Human Drugs

Support, Suggestions for Expedited IND Pilot

Five stakeholders support an FDA proposal for an expedited IND pilot program and suggest ways to improve it.

latest-news-card-1
Human Drugs

Court Upholds FDA Shortage Resolution Decision on Lillys Tirzepatide

The U.S. Court of Appeals for the Fifth Circuit upholds FDAs decision to remove tirzepatide from the agencys drug shortage list, a ruling that limits ...